Ebola medical therapy: Difference between revisions
Sergekorjian (talk | contribs) |
Sergekorjian (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Treatment for Ebola is primarily supportive. There are no targeted antiviral therapies currently in use. | Treatment for Ebola is primarily supportive. There are no targeted antiviral therapies currently in use. Symptoms of Ebola are treated as they appear. | ||
====Bleeding==== | ====Bleeding==== | ||
Replete [[coagulation factors]] with [[fresh frozen plasma]] if available, and [[transfusion|transfuse]] with packed red blood cells and platelets as needed. Invasive procedures should be avoided to prevent further bleeding. | Replete [[coagulation factors]] with [[fresh frozen plasma]] if available, and [[transfusion|transfuse]] with packed red blood cells and platelets as needed. Invasive procedures should be avoided to prevent further bleeding. | ||
Revision as of 22:37, 30 September 2014
|
Ebola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Postmortem Care |
|
Case Studies |
|
Ebola medical therapy On the Web |
|
American Roentgen Ray Society Images of Ebola medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Guillermo Rodriguez Nava, M.D. [2]
Overview
The treatment of Ebola infection is primarily supportive and includes maintaining fluids and electrolytes, homeostasis, adequate oxygen levels and blood pressure and treating any complicating superimposed infections.[1] All patients with a confirmed or suspected viral hemorrhagic fever should be put in isolation with adequate contact precautions.[2] No vaccine is currently available.
Medical Therapy
Treatment for Ebola is primarily supportive. There are no targeted antiviral therapies currently in use. Symptoms of Ebola are treated as they appear.
Bleeding
Replete coagulation factors with fresh frozen plasma if available, and transfuse with packed red blood cells and platelets as needed. Invasive procedures should be avoided to prevent further bleeding.
Dehydration
Replete with intravenous fluids that include electrolyte repletion.
Shock
Treat with a combination of intravenous fluids, vasopressors, and blood products as needed.
Hypoxia
Treat with supplemental oxygen including intubation if deemed necessary.
Superimposed Infections
Treating any complicating infections with empiric antibiotics.
References
- ↑ "CDC Ebola Hemorrhagic Fever Information Packet" (PDF). April 2010.
- ↑ Feldmann H, Geisbert TW (2011). "Ebola haemorrhagic fever". Lancet. 377 (9768): 849–62. doi:10.1016/S0140-6736(10)60667-8. PMC 3406178. PMID 21084112.